# Tuberculosis Prevention for HIV Infected Adults

> **NCT00057122** · PHASE3 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 1148 (actual)

## Conditions studied

- HIV Infections
- Tuberculosis

## Interventions

- **DRUG:** Isoniazid
- **DRUG:** Rifapentine
- **DRUG:** Rifampin

## Key facts

- **NCT ID:** NCT00057122
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** 2008-11
- **Final completion:** 2009-06
- **Target enrollment:** 1148 (ACTUAL)
- **Last updated:** 2012-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00057122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00057122, "Tuberculosis Prevention for HIV Infected Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00057122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*